# About KPV Compound: an independent KPV peptide research digest | KPV Compound

> KPV Compound is an independent editorial project that summarizes the peer-reviewed research literature on the KPV peptide. Not a clinic, not a vendor, no medical advice.

Two sides, read honestly: what the preclinical science establishes, and where compounded access actually stands. No clinic, no counter, no product.

## What KPV Compound is

KPV Compound is an independent editorial project that publishes summaries of the peer-reviewed research literature on the KPV peptide. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The site is built around a simple two-sided idea, which is also why it looks the way it does. On one side sits the research record — the PepT1-mediated gut uptake, the NF-kB and MAPK suppression, the murine-colitis and corneal-repair results — summarized in plain English and cited to source. On the other sits the access reality: KPV is a research compound with no human clinical trials, no validated human pharmacokinetics, and no FDA approval. We try to keep both sides legible at once, rather than letting the interesting science quietly erase the honest caveats.

## How to read the word "Compound" in our name

The "Compound" in KPV Compound is editorial framing, not a service claim. KPV is, literally, a chemical compound — a three-amino-acid peptide — and this site is a place to read about it. We are not a compounding pharmacy, we do not prepare or supply compounded medications, and nothing here is an offer to sell or source any substance.

That distinction matters most on the legal-status page, where we describe the FDA's 503A and 503B compounding framework in general terms. We report where KPV stands in that framework — a research peptide whose compounding eligibility is under FDA evaluation — and we cite the FDA. We do not advise anyone on obtaining it.

## Editorial standards

Every quantitative claim on this site — a concentration, a percentage, a species, a duration — maps to a numbered citation, and we verify identifiers against PubMed and Crossref rather than copying them from secondary web pages, where KPV PMID and DOI errors are common. We describe what studies measured, in which model, at which dose. We do not translate animal doses into human protocols, and we do not recommend use. Where the evidence is thin or absent — most importantly, the complete absence of human trials — we say so plainly rather than papering over it.

---

A two-sided reading of the KPV tripeptide record — the PepT1 gut-uptake and NF-kB findings logged to source on one plane, the research-only FDA status held plainly on the other; no clinic behind the seam and nothing here dispensed or sold.